SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001104659-21-140542
Filing Date
2021-11-17
Accepted
2021-11-17 16:01:32
Documents
1
Effectiveness Date
2021-11-17

Document Format Files

Seq Description Document Type Size
1 POSASR tm2133223d4_s3asr.htm POSASR 19629
  Complete submission text file 0001104659-21-140542.txt   20611
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-254443 | Film No.: 211420564
SIC: 2834 Pharmaceutical Preparations